The significance of oral health in HIV disease

Sexually Transmitted Infections

Volumn 76, Issue 4, 2000, Pages 236-243

  Chapple, Iain L C ^a   Hamburger, John ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; FOSCARNET; INDINAVIR; STEROID; THALIDOMIDE; VINBLASTINE; ZIDOVUDINE;

CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; FUSOBACTERIUM NUCLEATUM; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; KAPOSI SARCOMA; LEUKOPLAKIA; LYMPHOCYTE COUNT; META ANALYSIS; MOUTH DISEASE; MOUTH ULCER; NONHODGKIN LYMPHOMA; PATIENT REFERRAL; PERIODONTAL DISEASE; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND DISEASE; THRUSH; TREPONEMA; VIRUS LOAD;

CANDIDIASIS, ORAL; HERPES SIMPLEX; HIV INFECTIONS; HUMANS; LEUKOPLAKIA, HAIRY; LYMPHOMA, NON-HODGKIN; MOUTH DISEASES; MOUTH MUCOSA; ORAL ULCER; PERIODONTAL DISEASES; SALIVARY GLAND DISEASES; SARCOMA, KAPOSI;

EID: 0033816511     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.76.4.236     Document Type: Review

References (80)

1. 2, IL1-β, IL-6 and TNF-α by monocytes from early onset periodonitis patients. J Periodonol 1994;65:139-46.
2. 2 Beck J, Garcia R, Heiss G, et al. Periodontal disease and cardiovascular disease. J Periodontol 1996;67:1123-37.
3. 3 Chapple H.C, Rout PJ, Basu MK. Gingival Kaposi's sarcoma: the first indication of HIV infection. Dental Update 1992;296-301.
4. 4 Begg MD, Lamster IB, Panageas KS, et al. A prospective study of oral lesions and their predictive value for progres sion of HIV disease. Oral Diseases 1997;3:176-83.
5. 5 Centres for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993,41:1-19.
6. 6 Greenspan JS. Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease. Oral Diseases 1997;3:S13-17.
7. 7 Greenspan JS, Greenspan D. HIV-related oral disease. Lancet 1996;348:729-33.
8. 8 Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996. JAMA 1996;276: 146-54.
9. 9 Nielson H, Bensten KD, Hojtved L, et al. Oral candidosis and immune status of HIV-infected patients. J Oral Pathol Med 1994;23:140-3.
10. 10 Glick M, Muzyka BC, Lurie D, et al. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg, Oral Med, Oral Pathol 1994;77:344-9.
11. 11 EC Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral manifestations of the Immunodeficiency Virus. An update of the classification and diagnostic criteria of oral lesions in HIV infection. J Oral Pathol Med 1991;20:97-100.
12. 12 Greenspan JS, Barr CE, Sciubba JJ, et al. Oral manifestations of HIV infection: definitions, diagnostic criteria and principles of therapy. Oral Surg, Oral Med, Oral Pathol 1992;73:142-4.
13. 13 EC Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral manifestations of the Immunodeficiency Virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993;22:289-91.
14. 14 Greenspan D, Greenspan JS, Conant M, et al. Oral "hairy" leukoplakia in male homosexuals: evidence of association with papillomavirus and a herpes-group virus. Lancet 1984;ii:831-4.
15. 15 Felix DH, Jalal H, Cubie HA, et al. Detection of Epstein-Barr virus and human papillomavirus type 16 DNA in hairy leukoplakia by in-situ hybridisation and the polymerase chain reaction. J Oral Pathol Med 1993;22:277-81.
16. 16 Shiboski CH. Epidemiology of HIV-related oral manifestations in women: a review. Oral Diseases 1997;3:S18-27.
17. 17 Lifson AR, Hilton JF, Westenhouse JL, et al. Time from HIV seroconversion to oral candidosis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 1994;8:73-9.
18. 18 Tappero JW, Conant MA, Wolfe SF, et al. Kaposi's sarcoma. J Am Acad Dermatol 1993;28:371-95.
19. 19 Ficarra G, Eversole LE. HIV-related tumours of the oral cavity. Crit Rev Oral Biol Med 1994;5:159-85.
20. 20 Daly CG, Allan BP, Bhagwandeen SB, et al. Kaposi's sarcoma of the palate in a patient with AIDS: an unusual presentation. Aust Dent J 1988;34:101-5.
21. 21 Miller RF, Tomlinson MC, Cottrill CP, et al. Bronchopulmonary Kaposi's sarcoma in patients with AIDS. Thorax 1992;47:721-5.
22. 22 Orfanos CE, Husak R, Wolfer U, et al. Kaposi's sarcoma: a re-evaluation. Recent results. Cancer Res 1995;139:275-96.
23. 23 Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
24. 24 Moore PS, Gao SJ, Dominguez G, et al. Primary characterisation of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 1996;70:549-58.
25. 25 LeBourgeois JP, Frikha H, Piedbois P, et al. Radiotherapy in the management of epidemic Kaposi's sarcoma of the oral cavity, the eyelid and the genitals. Radiother Oncol 1994;30: 263-6.
26. 26 Piedbois P, Frikha H, Martin L, et al. Radiotherapy in the management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1994;30:1207-11.
27. 27 Evans MD, Yassa M, Podgorsak EB, et al. Surface applicators for high dose rate brachytherapy in AIDS-related Kaposi's sarcoma. Intl J Radiat Oncol Biol Phys 1997;39:769-74.
28. 28 Epstein JB. Treatment of oral Kaposi's sarcoma with intralesional vinblastine. Cancer 1993;71:1722-5.
29. 20 Epstein JB, Silverman S Jr. Head and neck malignancies associated with HIV infection. Oral Surg, Oral Med, Oral Pathol 1992; 73: 193-300.
30. 30 Beral V. Epidemiology of cancer in AIDS patients. AIDS 1991;5:S99-103.
31. 31 Boring CC, Brynes RK, Chan WC, et al. Increase in high grade lymphomas in young men. Lancet 1985;1:857-9.
32. 32 Piluso S, Di Lollo S, Baroni G, et al. Unusual clinical aspects of oral non-Hodgkin's lymphomas in patients with HIV infection. Oral Oncol, Eur J Cancer 1994;30B:61-4.
33. 33 Ramos-Gomez FJ. Oral aspects of HIV disease in children. Oral Diseases 1997;3(Suppl 1):S31-5.
34. 34 Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992;80:8-20.
35. 35 Delecluse HJ, Anagnostopoulos I, Dallenback F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997;89:1413-14.
36. 36 Boshoff C, Whitby D, Talbot S, et al. Aetiology of AIDS-related Kaposi's sarcoma and lymphoma. Oral Diseases 1997;3(Suppl 1):S129-32.
37. 37 Silverman S Jr. Colour atlas of oral manifestations of AIDS. 2nd ed. St Louis: Mosby, 1996:101-4.
38. 38 Klein RS, Harris CA, Small CB, et al. Oral candidiasis in high risk patients as the initial manifestation of the acquired immunodeficincy syndrome. N Engl J Med 1984;311:354-57.
39. 39 Samaranayake LP. Oral mycoses in HIV infection. Oral Surg, Oral Med, Oral Pathol 1992;73:171-80.
40. 40 Korting HC, Ollert M, Georgii A, et al. In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients with human immunodeficiency virus. J Clin Microbiol 1989;26:2626-31.
41. 41 Samaranayake LP. Oral candidosis: predisposing factors and pathogenesis. In: Derrick DD, ed. Dental annual 1989. Bristol: Wright, 1989:219-35.
42. 42 MacPhail L, Hilton J, Heinic G, et al. Direct immunofluorescence vs culture for detecting HSV in oral ulcers: a comparison. JADA 1995;126:74-8.
43. 43 Reichart PA. Oral ulcerations in HIV infection. Oral Diseases 1997;3:S180-2.
44. 44 Regezi J, Eversole R, Barker B, et al. Herpes simplex and cytomegalovirus co-infected oral ulcers in HIV-positive patients. Oral Surg, Oral Med, Oral Pathol, Oral Radiol 1996;81:55-62.
45. 45 Eversole L. Viral infections of the head and neck upon HIV-seropositive patients. Oral Surg, Oral Med, Oral Pathol 1992;73:155-63.
46. 46 Jacobson M, Berger T, Fikrig S, et al. Acyclovir resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1992;112:187-91.
47. 47 MacPhail LA, Greenspan JS. Oral ulceration in HIV infection: investigation and pathogenesis. Oral Diseases 1997;3(Suppl 1):S190-3.
48. 48 Gilquin J, Wiss L, Kazatchkine MD, et al. Genital and oral erosions induced by foscarnet. Lancet 1990;335:287.
49. 49 Reichert P. Oral ulceration and iatrogenic disease in HIV infection. Oral Surg, Oral Med, Oral Pathol 1992;73:212-14.
50. 50 Rzany B, Mockenhaupt M, Stocker U, et al. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with acquired immunodeficiency syndrome in Germany. Arch Dermatol 1993;129:1059-64.
51. 51 Flaitz CM, Nichols CM, Adler-Stothz K, et al. Intraoral squamous cell carcinoma in HIV infection: a clinicopathological study. Oral Surg, Oral Med, Oral Pathol 1995;80:55-62.
52. 52 Ficarra G, Eversole R. HIV-related tumours of the oral cavity. Crit Rev Oral Biol Med 1994;5:159-85.
53. 53 Ficarra G. Oral ulcerations in patients with HIV infection: aetiology, diagnosis and management. In: Greenspan JS, Greenspan D eds. Proceedings of the II International Workshop on Oral Manifestations of HIV Infection. Chicago: Quintessence Publishing Co, 1995:205-17.
54. 54 Schmidt-Westhausen A, Grunewald TH, Reichart PA, et al. Oral cryptococcosis in a patient with AIDS. A case report. Oral Dis 1995;1:77-9.
55. 55 Swindells S, Durham T, Johansson SL, et al. Oral histoplasmosis in a patient infected with HIV. A case report. Oral Surg, Oral Med, Oral Pathol 1994;77:126-30.
56. 56 Robinson P, Farthing P, Scott GM, et al. Oral Mycobacterium avium complex infection in a patient with HIV-related disease. A case report. Oral Surg, Oral Med, Oral Pathol 1996;81:177-9.
57. 57 Ghigliotti G, Repetto T, Farris A, et al. Thalidomide for severe aphthous ulceration in patients with HIV infection. J Am Acad Dermatol 1993;28:271-2.
58. 58 Grbic JT, Mitchell-Lewis DA, Fine JB, et al. The relationship of candidosis to linear gingival erythema in HIV-infected homosexual men and parenteral drug users. J Periodontol 1995,66:30-7.
59. 59 Robinson PG, Sheiham A, Challacombe SJ, et al. Gingival ulceration in HIV infection. A case series and case control study. J Periodontol 1998;25:260-7.
60. 60 Glick M, Muzyka BC, Slakin LM, et al. Necrotizing ulcerative periodontitis: a marker for immune deterioration and a predictor for the diagnosis of AIDS. J Periodontol 1994;65: 393-7.
61. 61 Felix DH, Wray D, Smith GLF, et al. Oral-antral fistula: an unusual complication of HIV-associated periodontal disease. Br Dent J 1991;171:61-2.
62. 62 Todd JE, Lader D. 1988 Adult dental health survey of the United Kingdom. London: Office of Population Censuses and Surveys, Social Division, 1991:131-44.
63. 63 Smith GLF, Cross DL, Wray D. Comparison of periodontal disease in HIV seropositive subjects and controls (I). Clinical features. J Clin Periodontol 1995;22:558-68.
64. 64 Cross DL, Smith GLF. Comparison of periodontal disease in HIV seropositive subjects and controls (II). Microbiology, immunology and predictors of disease progression. J Clin Periodontol 1995;22:569-77.
65. 65 Yeh C-K, Fox PC, Travis WD, et al. Kaposi's sarcoma of the parotid gland in acquired immunodeficiency syndrome. Oral Surg, Oral Med, Oral Pathol 1989;67:308-12.
66. 66 Ioachim HL, Ryan JR, Blaugrand SM. Salivary gland lymph nodes: the site of lymphadenopathies and lymphomas associated with human immunodeficiency virus infection. Arch Pathol Lab Med 1988;112:1224-8.
67. 67 Shugar JMA, Som PM, Jacobsen AL, et al. Multicentric parotid cysts and cervical adenopathy in AIDS patients: a newly recognised entity - CT and MR manifestations. Laryngoscope 1988;20:355-7.
68. 68 Itescu S, Winchester R. Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome. Rheum Dis N Am 1990;118:683-97.
69. 69 Schiodt M, Greenspan D, Daniels TE, et al. Parotid gland enlargement and xerostomia associated with labial sialadenitis in HIV-infected patients. J Autoimmun 1989;2:415-25.
70. 70 Katz MH, Mastrucci MT, Leggott PJ, et al. Prognostic significance of oral lesions in children with perinatally acquired human immunodeficiency virus syndrome. Am J Dis Child 1993;147:45-8.
71. 71 Schiodt M. Less common oral lesions associated with HIV infection:prevalence and classification. Oral Diseases 1997; 3(Suppl 1):S208-213.
72. 72 Porter SR, Scully C. HIV topic update: protease inhibitor therapy and oral health care. Oral Diseases 1998;4:159-63.
73. 73 Cauda R, Tacconelli E, Tumbarello M, et al. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. J Acquir Immun Defic Synd 1999;21:20-5.
74. 74 Shugars DC, Alexander AL, Fu K, et al. Endogenous salivary inhibitors of human immunodeficiency virus. Arch Oral Biol 1999;44:445-53.
75. 75 Malamud D, Davis C, Berthold P, et al. Human submandibular saliva aggregates HIV. AIDS Res Hum Retrovir 1993;9:633-7.
76. 76 Thompson RC, Ohlsson K. Isolation, properties and complete amino acid sequences of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 1986;83:6692-6.
77. 77 Shugars DC, Sauls DL, Weinberg JB. Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type 1. Oral Diseases 1997;3:S70-2.
78. 78 Cruz G, Lamster I, Begg MD, et al. The accurate diagnosis of oral lesions in HIV infection: impact on medical staging. Arch Otolaryng Head Neck Surg 1996;122:68-73.
79. 79 Paauw DS, Wenrich MD, Curtis R, et al. Ability of primary care physicians to recognise physical findings associated with HIV infection. JAMA 1995;274:1380-2.
80. 80 Kitahata MM, Koepsell TD, Deyo RA, et al. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med 1996;334: 701-6.